In this article you will learn about the practical role of automation and integrated data handling in orally inhaled and nasal drug product (OINDP) testing. Our Head of Business Developmet, Paul Martin, explains why fully automated OINDP testing remains challenging, how selective semi-automation can reduce manual variability, and why connected, ecosystem-based workflows are increasingly important for improving data integrity, efficiency and regulatory confidence.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer April 2026, Inhalation Technology Supplement, pages 32-35. © Samedan Ltd.
